These blood thinners may have an unexpected benefit for Alzheimer’s patients

People who have both atrial fibrillation and Alzheimer’s disease may experience slower cognitive decline when treated with newer NOAC blood thinners, according to research from Karolinska Institutet published in the European Heart Journal.

Click here to view the original article.